Today: 22 May 2026
Alphabet (GOOG) stock ticks up after-hours as Google sets Feb. 4 earnings call, CEO sale disclosed
9 January 2026
1 min read

Alphabet (GOOG) stock ticks up after-hours as Google sets Feb. 4 earnings call, CEO sale disclosed

NEW YORK, Jan 9, 2026, 16:37 EST — After-hours

  • Alphabet’s Class C shares added about 1% in after-hours trading.
  • Google’s parent company scheduled Feb. 4 to report quarterly results and hold an earnings call.
  • A filing showed CEO Sundar Pichai sold 32,500 Class C shares on Jan. 7.

Alphabet’s Class C shares added about 1% to $329.14 in after-hours trading Friday.

Traders are also eyeing two dates in the near term: Alphabet set Feb. 4 for its fourth-quarter and full-year 2025 results and conference call, due after the close at 4:30 p.m. ET. The Class C shares (GOOG) have no voting rights; Class A (GOOGL) gets one vote per share.

Cantor Fitzgerald, in Street calls tracked by TipRanks, upgraded Alphabet to “overweight” from “neutral” and raised its price target to $370 from $310. “Overweight” is analyst shorthand for expecting a stock to beat its sector or coverage universe. In a note cited by MarketWatch, Cantor’s Deepak Mathivanan dubbed Alphabet the “king of all AI trades.” TipRanks

A filing showed Chief Executive Sundar Pichai unloaded 32,500 Class C shares on Jan. 7 across multiple transactions for about $10.4 million. That left him holding 2,244,372 Class C shares and 227,560 Class A shares. The Form 4 said the sales were made under a Rule 10b5-1 plan — a pre-arranged trading program that sets conditions for future stock sales.

Regulators remain an overhang. EU antitrust authorities are due by Feb. 10 to say whether they’ll clear Alphabet’s $32 billion purchase of cybersecurity company Wiz — its biggest deal — according to a European Commission filing reported by Reuters. The Commission could clear the deal outright, clear it with remedies, or open a deeper investigation.

In Washington, three Democratic U.S. senators called on Apple and Google to pull X and its Grok chatbot from their app stores over the spread of nonconsensual sexual images, Reuters reported — another case where app-store policing can quickly turn into a political brawl. Google did not immediately comment, Reuters said.

Big-cap tech caught a bid late Friday, with the Invesco QQQ Trust up about 1% and the SPDR S&P 500 ETF up about 0.6%.

Even so, the run-up to earnings isn’t straightforward. Investors still have to judge whether stepped-up AI and data-center spending keeps pressuring margins, and whether regulators muddy the Wiz deal or dial up scrutiny of Google’s platform rules.

Still to come: Alphabet’s results and management commentary after the close on Feb. 4, with focus on advertising trends, Google Cloud demand and any update on the Wiz timetable.

Stock Market Today

  • NYSE's Martin Questions Nasdaq Rules Attracting SpaceX IPO
    May 22, 2026, 9:22 AM EDT. Lynn Martin, President of the New York Stock Exchange (NYSE), criticized some of the Nasdaq's listing rules used to attract SpaceX's public offering as "questionable." Speaking on Bloomberg Surveillance, Martin emphasized that market integrity should not be compromised for competitive gains between stock exchanges. She noted 2023 has been a strong year for initial public offerings (IPOs) across sectors and affirmed the NYSE's commitment to bringing more companies public. Martin's remarks highlight ongoing debates over regulatory standards and competitive practices in the IPO market.

Latest articles

Akari Therapeutics Stock Is Soaring Again — The KRAS Cancer Data Behind the Move

Akari Therapeutics Stock Is Soaring Again — The KRAS Cancer Data Behind the Move

22 May 2026
New York, May 22, 2026, 09:08 EDT Akari Therapeutics shares were indicated sharply higher before the Nasdaq open on Friday, after the oncology biotech said its lead cancer drug candidate showed positive preclinical activity in KRAS-mutated pancreatic cancer models and priced a $5.5 million private placement. The stock closed Thursday at $5.14, up 49.85%, and was quoted at $10.15 in premarket trading at 8:39 a.m. EDT, according to StockAnalysis. The move matters because Akari is still a preclinical company, not a revenue-producing drugmaker. Its latest data give investors a fresh reason to look at AKTX-101, while the financing gives the
BMO Lands Buy Rating Ahead of Earnings But Targets Raise Questions

BMO Lands Buy Rating Ahead of Earnings But Targets Raise Questions

22 May 2026
Canaccord Genuity reaffirmed a Buy rating on Bank of Montreal ahead of its May 27 earnings report. BMO shares closed May 21 at C$220.06, near a 52-week high and up 23.5% year-to-date. The bank recently agreed to sell C$14.5 billion in loan and lease assets to Stonepeak, expecting a CET1 ratio boost but a C$900 million after-tax charge. Analyst consensus remains mixed, with most holding or selling.
Atmos Energy’s run in Texas faces new Wall Street target cut

Atmos Energy’s run in Texas faces new Wall Street target cut

22 May 2026
Morgan Stanley lowered its Atmos Energy price target to $183 from $195, maintaining an Equalweight rating. The move follows Atmos’ recent increase in its 2026 earnings outlook and annual dividend. Atmos shares closed at $177.46 on Thursday. Texas remains central to Atmos’ growth and regulatory strategy, with 65% of its rate base in the state.
Nvidia stock holds steady after China H200 pay-upfront report — what AI investors watch next
Previous Story

Nvidia stock holds steady after China H200 pay-upfront report — what AI investors watch next

Applied Digital stock jumps again as AI data-center demand and hyperscaler talks drive the tape
Next Story

Applied Digital stock jumps again as AI data-center demand and hyperscaler talks drive the tape

Go toTop